In a research report issued December 7, 2014, Wedbush analyst Liana Moussatos maintained an Outperform rating on Intercept Pharmaceuticals (NASDAQ:ICPT), as the company announced …
Wedbush analyst Liana Moussatos reiterated an Outperform rating on Omeros (NASDAQ:OMER) with a $52 price target, after the company announced positive data using OMS721, the …
In a research note issued today, Wedbush analyst Liana Moussatos reiterated an Outperform on La Jolla Pharmaceutical (NASDAQ:LJPC) with a $45 price target …
In a research report released yesterday, Wedbush analyst Liana Moussatos reiterated an Outperform rating on Pacira Pharmaceuticals (NASDAQ:PCRX) with a $117 price target, following Moussatos’s …
In a report issued today, analyst Liana Moussatos of Wedbush reiterated an Outperform rating on Pacira Pharmaceuticals (NASDAQ:PCRX) with a $117 price target, as the company recently announced …
In a research report published yesterday, Wedbush analyst Liana Moussatos reiterated a Neutral rating on Biodel (NASDAQ:BIOD) with a $3 price target ahead of …
In a research note published yesterday, Wedbush analyst Liana Moussatos reiterated an Outperform rating on Sangamo BioSciences (NASDAQ:SGMO) and raised her price target …
In a report issued yesterday, Wedbush analyst Liana Moussatos reiterated an Outperform rating on La Jolla Pharaceutical Co. (NASDAQ:LJPC) with a $45 price target, …
In a report issued yesterday, Wedbush analyst Liana Moussatos reiterated an Underperform rating on Regado Bioscoences (NASDAQ:RGDO) and reduced her price target to $1 …
Analyst Liana Moussatos of Wedbush yesterday reiterated an Underperform rating on Regado Biosciences (NASDAQ:RGDO), with a $2 price target, after the company released its second-quarter financials. Moussatos notes: …
